Singapore
Also, Lunit has completed its acquisition of breast screening AI company Volpara.
The wearable device enables scientists to hasten their analysis of skincare cosmetic products by up to 10 times.
It also incorporates gamification to encourage self-health monitoring.
It looks to onboard new commercial partners and further validate its products.
Also, SELVAS Healthcare will be bringing to South Korea a foreign contender to the booming AI-based medical imaging market.
Also, researchers from Singapore and Kazakhstan have used AI and heat imaging for the early detection of breast cancer.
Also, Seegene will be leveraging Microsoft's AI to advance the development of syndromic quantitative PCR diagnostic tests globally.
This comes three months after getting regulatory approval from Singapore’s Health Sciences Authority for its latest digital twin solution.
Also, Qure.ai has received its 13th FDA approval for its AI-based medical imaging software.
The mobile app developed by NUS Nursing can also help raise the developmental outcomes of infants.